Enhancing the use of MedDRA in an intelligent online adverse event reporting portal

The process of drug development requires close monitoring of medical events experienced by patients both during clinical trials and post-marketing. Without this critical safeguard, patient safety is put at risk, as well as jeopardizing company¬†reputation, loss of revenue and fall in share price if a product is subsequently withdrawn. Such diligent monitoring relies upon comprehensive reporting together¬†with accurate statistical evaluation. …